Leguisan, Mario M.
HRN: 28-04-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2025
MUPIROCIN 2%, 15G (TUBE)
11/04/2025
11/10/2025
TOPICAL
APLLY ON AFFECTED AREA
BID
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes